Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Boston Scientific (BSX) shares

Learn how to easily invest in Boston Scientific shares.

Boston Scientific Corporation (BSX) is a leading medical devices business based in the US. It opened the day at USD$40.38 after a previous close of USD$40.43. During the day the price has varied from a low of USD$40.125 to a high of USD$41.48. The latest price was USD$40.86 (25 minute delay). Boston Scientific is listed on the NYSE and employs 41,000 staff. All prices are listed in US Dollars.

How to buy shares in Boston Scientific

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – BSX – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Compare share trading platforms

Name Product Available Investment Types Min. Monthly Fee Available Markets
Sharesies
Shares, ETFs, Managed Funds, Index Funds
$0
US, NZ, AU, Funds with exposure to multiple markets
Trade and invest in more than 8,000 companies, ETFs and managed funds across New Zealand, the US and Australia.
OFFER
BlackBull Markets Share Trading
Shares
$0
US, NZ, AU, Funds with exposure to multiple markets
Exclusive: Sign up through Finder and get 5 free shares with a minimum first time deposit of $1,000. T&Cs apply.
Trade 23,000+ shares and access 80+ global markets across the US, New Zealand, Australia and more, plus benefit from extended trading hours, no monthly fees, 24/6 dedicated local support and a mobile trading app available on both Android and iOS.
Rockfort Markets Share Trading
Rockfort Markets Share Trading
Shares
$20
US, AU, Funds with exposure to multiple markets
Trade shares in more than 1000 companies across the US, Australia and more.
Low brokerage on trades, plus access to professional tools, research and live market data. Available on desktop and mobile.
OFFER
Tiger Brokers
Shares, ETFs, Options
$0
US, AU, Funds with exposure to multiple markets
Sign up to Tiger Brokers and get a free stock voucher worth NZ$10, plus receive 3 Rocket Lab shares and one lucky draw ticket to win a free share when you deposit at least NZ$500 into your Tiger account. Offer is for new clients only and is subject to minimum deposit requirements. T&Cs apply.
Trade shares in more than 7,000 companies across the US, Australia and Asia.
OFFER
Hatch
Shares, ETFs
$0
US
Sign up to Hatch through Finder and get a $20 top-up when you deposit $100 or more.
Invest in more than 4,100 US companies and exchange-traded funds (ETFs) - no minimum investment or monthly fees.
OFFER
Stake
Shares
$0
US
Sign up through Finder and use referral code "FINDERNZ" for a free stock valued up to US$150.
Trade more than 4,500 US-listed stocks and ETFs through Stake with $0 fees on trades.
loading

Compare up to 4 providers

Boston Scientific shares at a glance

Information last updated 2021-12-17.
Open$40.38
High$41.48
Low$40.13
Close$40.86
Previous close$40.43
Change $0.43
Change % 1.0636%
Volume 9,850,850
Information last updated 2022-05-23.
52-week range$37.96 - $47.50
50-day moving average $42.86
200-day moving average $43.00
Wall St. target price$50.38
PE ratio 74
Dividend yield $0 (0%)
Earnings per share (TTM) $0.53

Boston Scientific stock price (NYSE:BSX)

Use our graph to track the performance of BSX stocks over time.

Boston Scientific price performance over time

Historical closes compared with the close of $40.86 from 2022-05-25

1 week (2022-05-18) 1.57%
1 month (2022-04-22) N/A
3 months (2022-02-23) -6.52%
6 months (2021-11-26) 5.94%
1 year (2021-05-26) -2.32%
2 years (2020-05-26) 12.90%
3 years (2019-05-24) 6.21%
5 years (2017-05-26) 49.56%

Is Boston Scientific under- or over-valued?

Valuing Boston Scientific stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Boston Scientific's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Boston Scientific's P/E ratio

Boston Scientific's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 74x. In other words, Boston Scientific shares trade at around 74x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

Boston Scientific's PEG ratio

Boston Scientific's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 2.3897. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Boston Scientific's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

Boston Scientific's EBITDA

Boston Scientific's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $3.2 billion.

The EBITDA is a measure of a Boston Scientific's overall financial performance and is widely used to measure a its profitability.

Boston Scientific financials

Revenue TTM $12.2 billion
Operating margin TTM 17.47%
Gross profit TTM $8.2 billion
Return on assets TTM 4.2%
Return on equity TTM 4.99%
Profit margin 6.66%
Book value $11.71
Market capitalisation $56.1 billion

TTM: trailing 12 months

Boston Scientific's environmental, social and governance track record

Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like Boston Scientific.

When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.

Boston Scientific's total ESG risk score

Total ESG risk: 29.23

Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and Boston Scientific's overall score of 29.23 (as at 12/31/2018) is nothing to write home about – landing it in it in the 57th percentile of companies rated in the same sector.

ESG scores are increasingly used to estimate the level of risk a company like Boston Scientific is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).

Boston Scientific's environmental score

Environmental score: 1.51/100

Boston Scientific's social score

Social score: 12.87/100

Boston Scientific's governance score

Governance score: 7.87/100

Boston Scientific's controversy score

Controversy score: 3/5

ESG scores also evaluate any incidences of controversy that a company has been involved in. Boston Scientific scored a 3 out of 5 for controversy – a middle-of-the-table result reflecting that Boston Scientific hasn't always managed to keep its nose clean.

Boston Scientific share dividends

We're not expecting Boston Scientific to pay a dividend over the next 12 months.

Have Boston Scientific's shares ever split?

Boston Scientific's shares were split on a 2:1 basis on 5 November 2003. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your Boston Scientific shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for Boston Scientific shares which in turn could have impacted Boston Scientific's share price.

Boston Scientific share price volatility

Over the last 12 months, Boston Scientific's shares have ranged in value from as little as $37.96 up to $47.5. A popular way to gauge a stock's volatility is its "beta".

BSX.US volatility(beta: 0.81)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Boston Scientific's is 0.8147. This would suggest that Boston Scientific's shares are less volatile than average (for this exchange).

Boston Scientific overview

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various urological and pelvic conditions; implantable cardioverter and implantable cardiac resynchronization therapy defibrillators; pacemakers and implantable cardiac resynchronization therapy pacemakers; and remote patient management systems. It also provides medical technologies to diagnose and treat rate and rhythm disorders of the heart comprising 3-D cardiac mapping and navigation solutions, ablation catheters, diagnostic catheters, mapping catheters, intracardiac ultrasound catheters, delivery sheaths, and other accessories; spinal cord stimulator systems for the management of chronic pain; indirect decompression systems; and deep brain stimulation systems. In addition, the company offers interventional cardiology products, including drug-eluting coronary stent systems used in the treatment of coronary artery disease; percutaneous coronary interventions products to treat atherosclerosis; intravascular catheter-directed ultrasound imaging catheters, fractional flow reserve devices, and systems for use in coronary arteries and heart chambers, as well as various peripheral vessels; and structural heart therapies. Further, it provides stents, balloon catheters, wires, and atherectomy systems to treat arterial diseases; thrombectomy and acoustic pulse thrombolysis systems, wires, and stents to treat venous diseases; and peripheral embolization devices, radioactive microspheres, ablation systems, cryotherapy ablation systems, and micro and drainage catheters to treat cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.

Frequently asked questions

Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involve substantial risk of loss and therefore are not appropriate for all investors. Past performance is not an indication of future results. Consider your own circumstances and obtain your own advice before making any trades.

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use, Disclaimer & Privacy Policy.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site